EXPERT REV MOL DIAGN
| 中国学者近期发表的论文 | |
|---|---|
| 1. | Theranostics meets traditional Chinese medicine: rational prediction of drug-herb interactions. Author: Hu M, Fan L, Zhou HH, Tomlinson B. Journal: Expert Rev Mol Diagn. 2012 Nov;12(8):815-30. doi: 10.1586/erm.12.126. |
| 2. | Noninvasive fetal trisomy 21 detection using chromosome-selective sequencing: a variation of the molecular counting theme. Author: Lo YM, Chan KC, Chiu RW. Journal: Expert Rev Mol Diagn. 2012 May;12(4):329-31. doi: 10.1586/erm.12.24. |
| 3. | Epigenetic and genetic alterations-based molecular classification of head and neck cancer. Author: Feng Z, Xu Q, Chen W. Journal: Expert Rev Mol Diagn. 2012 Apr;12(3):279-90. doi: 10.1586/erm.12.19. |
| 4. | A systematic evaluation for the potential translation of CD166-related expression as a cancer biomarker. Author: Xiao M, Wang X, Yan M, Chen W. Journal: Expert Rev Mol Diagn. 2016 Jul 11. [Epub ahead of print] |
| 5. | EGFR mutations in non-small cell lung cancer: an audit from West China Hospital. Author: Tang Y, Wang WY, Zheng K, Jiang L, Zou Y, Su XY, Chen J, Zhang WY, Liu WP. Journal: Expert Rev Mol Diagn. 2016 Aug;16(8):915-9. doi: 10.1080/14737159.2016.1199961. Epub 2016 Jun 28. |
| 6. | Advances in addressing technical challenges of point-of-care diagnostics in resource-limited settings. Author: Wang S, Lifson MA, Inci F, Liang LG, Sheng YF, Demirci U. Journal: Expert Rev Mol Diagn. 2016 Apr;16(4):449-59. doi: 10.1586/14737159.2016.1142877. Epub 2016 Feb 24. |
| 7. | Histone modifying enzymes: novel disease biomarkers and assay development. Author: Ma F, Zhang CY. Journal: Expert Rev Mol Diagn. 2016;16(3):297-306. doi: 10.1586/14737159.2016.1135057. Epub 2016 Jan 11. |
| 8. | Standardising HbA1c-based diabetes diagnosis: opportunities and challenges. Author: Jia W. Journal: Expert Rev Mol Diagn. 2016;16(3):343-55. doi: 10.1586/14737159.2016.1133299. Epub 2016 Jan 4. |